Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
1068 Innate and adaptive immune responses and antitumor activity associated with ARV-6723, a PROTAC HPK1 degrader, in exhausted/post-immune checkpoint inhibitor (ICI) preclinical settings
- 1Arvinas Operations, Inc., New Haven, CT, USA
- 22Arvinas Operations, Inc., New Haven, CT, USA
Related
- m6A-modified mRNA–LNP system enables in vivo CAR expression and is associated with antitumor immune responses
- Ascorbic Acid Potentiates Cisplatin-Induced Antitumor Activity in HeLa Cervical Cancer Cells: Oxidative Stress, Mitochondrial Dysfunction, Apoptosis, and 3D Spheroid Responses
- BRCA1 Mutation-Recognizing Tetrahedral Framework Nucleic Acid Nanoplatform Enables Coordinated PARP/WEE1 Inhibition and STING-Associated Antitumor Immunity in Ovarian Cancer.
- Butyrate-associated antiproliferative and antitumor effects of Eubacterium limosum KGMB01548 in colorectal cancer
- Probiotic-hydrogel systems for microbiome-associated diseases: design principles, preclinical evidence, and translational challenges.
BibTeX
@article{wu20261068,
title = {{1068 Innate and adaptive immune responses and antitumor activity associated with ARV-6723, a PROTAC HPK1 degrader, in exhausted/post-immune checkpoint inhibitor (ICI) preclinical settings}},
author = {Wendy Wu and Rebecca Conrad and Morena Scopel and John Corradi and Kim Davenport and Gregory Cadelina and Jennifer Pizzano and Angela Cacace and Anna C Van Acker and William Corwin and Albert DeBerardinis and Christopher Kuhlberg and Eric Masson and Ignacio J Juncadella and Sean Landrette and XiaoZhe (Janet) Wang},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.1068},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.1068},
note = {CC BY},
}
RIS
TY - JOUR
TI - 1068 Innate and adaptive immune responses and antitumor activity associated with ARV-6723, a PROTAC HPK1 degrader, in exhausted/post-immune checkpoint inhibitor (ICI) preclinical settings
AU - Wendy Wu
AU - Rebecca Conrad
AU - Morena Scopel
AU - John Corradi
AU - Kim Davenport
AU - Gregory Cadelina
AU - Jennifer Pizzano
AU - Angela Cacace
AU - Anna C Van Acker
AU - William Corwin
AU - Albert DeBerardinis
AU - Christopher Kuhlberg
AU - Eric Masson
AU - Ignacio J Juncadella
AU - Sean Landrette
AU - XiaoZhe (Janet) Wang
PY - 2026
DA - 2026/11/04
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.1068
UR - https://doi.org/10.1136/jitc-2026-sitc2026.1068
SN - 2051-1426
ER -